The other three witnesses pressed on and commented on a broad range of pricing and healthcare transparency issues. They were:
While there was general agreement that price and quality transparency will help consumers more wisely spend their healthcare dollars, there was considerable handwringing over the role transparency can play in resolving the high cost of healthcare.
"I am concerned that policy makers have focused too much concern on the amount of information available rather than the reliability and usefulness of that information," stated Sen. Orrin Hatch (R-UT), ranking member of the committee.
The discussion between the panelists and Senate committee members was framed around several broad issues. As is typical of these hearings there were a lot of questions and dearth of specific recommendations: